DEXCOM, INC. Treasury Stock Acquired, Average Cost Per Share
DEXCOM, INC. (DXCM) reported Treasury Stock Acquired, Average Cost Per Share of $118.12 per share for the 1-month period ending 2023-05-31, per its 10-K filed 2024-02-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:TreasuryStockAcquiredAverageCostPerShare · last filed 2024-02-08
- 2023-05-31: Treasury Stock Acquired, Average Cost Per Share 1 month $118.12.
| Period end | Treasury Stock Acquired, Average Cost Per Share 1 month |
|---|---|
| 2023-05-31 | $118.12 10-K · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |